Evidence map›Paper›PMID 42766650›Full record

ArticlePLoS neglected tropical diseases2026

Genome variation of Sporothrix schenckii and Sporothrix brasiliensis.

Ujwal R Bagal, Amanda R Santos, Rodrigo Almeida Paes, Lucas Gomes de Brito Alves, Luz Rocio Chamorro, Lindsay A Parnell, Jose Pereira Brunelli, Nancy A Chow, Jan Pohl, Vanessa Rabello Brito and 11 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ujwal R BagalMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Amanda R SantosMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Rodrigo Almeida PaesInstituto Nacional de Infectologia Evandro Chagas: Rio de Janeiro, Rio de Janeiro, Brazil.
Lucas Gomes de Brito AlvesNúcleo de Medicina Tropical, Faculty of Medicine, University of Brasília, Brasília, Distrito Federal, Brazil.
Luz Rocio ChamorroNúcleo de Medicina Tropical, Faculty of Medicine, University of Brasília, Brasília, Distrito Federal, Brazil.
Lindsay A ParnellMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Jose Pereira BrunelliMinistry of Public Health and Social Welfare, Asuncion, Paraguay.
Nancy A ChowMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Jan PohlBiotechnology Core Facility Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Vanessa Rabello BritoInstituto Nacional de Infectologia Evandro Chagas: Rio de Janeiro, Rio de Janeiro, Brazil.
Vanice Rodrigues PoesterSchool of Medicine, Federal University of Rio Grande (FURG), Rio Grande, Rio Grande do Sul, Brazil.
Bram SpruijtenburgRadboudumc-CWZ Center of Expertise for Mycology, Nijmegen, The Netherlands.
Larissa FernandesFaculty of Ceilandia, University of Brasilia, Brasilia, Distrito Federal, Brazil.
Bridget M BarkerPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
Jason E StajichDepartment of Microbiology and Plant Pathology, University of California-Riverside, Riverside, California, United States of America.
Maria Sueli FelipeGenomic Sciences and Biotechnology Graduate Program, Universidade Católica de Brasília (UCB), Brasília, Distrito Federal, Brazil.
Johanna RhodesSchool of Biosciences, University of Birmingham, Birmingham, United Kingdom.
Melissa Orzechowski XavierSchool of Medicine, Federal University of Rio Grande (FURG), Rio Grande, Rio Grande do Sul, Brazil.
Daniel R MatuteUniversity of North Carolina, Chapel Hill, North Carolina, United States of America.
Rosely ZancopeInstituto Nacional de Infectologia Evandro Chagas: Rio de Janeiro, Rio de Janeiro, Brazil.
Marcus de Melo TeixeiraNúcleo de Medicina Tropical, Faculty of Medicine, University of Brasília, Brasília, Distrito Federal, Brazil.ORCID https://orcid.org/0000-0003-1763-3464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporotrichosis, a subcutaneous mycosis caused by dimorphic fungi of the Sporothrix genus, has become a major zoonotic epidemic in South America, primarily driven by Sporothrix brasiliensis. To elucidate the genomic basis of its emergence and antifungal adaptation, we analyzed whole-genome sequences from 95 Sporothrix isolates, integrating single-nucleotide polymorphism (SNP), copy number variation (CNV), and genome-wide association (GWAS) analyses. Comparative genomics revealed 610,242 SNPs within S. brasiliensis and 1,474,627 within S. schenckii, confirming a marked disparity in intraspecific diversity. Phylogenomic tree inference resolved six well-supported S. brasiliensis clades with limited internal divergence, reflecting recent population expansion, while S. schenckii displayed deep phylogeographic structure separating North and South American lineages. CNV profiling identified 158 affected genes in S. brasiliensis (60 gains, 98 losses) and 88 in S. schenckii (54 gains, 34 losses), concentrated near sub-telomeric regions. In S. brasiliensis, gains were enriched for kinases and intracellular trafficking functions, whereas losses involved genes related to translation and primary metabolism, suggesting regulatory reinforcement coupled with metabolic streamlining. A GWAS of itraconazole resistance identified 81 SNPs distributed across multiple scaffolds, with many located within genes related with transport, signaling, and redox balance, supporting a polygenic basis for azole response. The implication of these alleles with itraconazole resistance warrants experimental followup. Together, these results highlight distinct evolutionary strategies of closely related Sporothrix species and pinpoint genomic changes potentially associated with the emergence and drug tolerance of S. brasiliensis.

Indexed as

Genetic VariationGenome, FungalSporothrixSporotrichosisAnimalsAntifungal AgentsDNA Copy Number VariationsGenome-Wide Association StudyHumansPhylogenyPhylogeographyPolymorphism, Single NucleotideSouth AmericaWhole Genome SequencingAntifungal Agents

Identifiers

PMID42766650
PMCPMC13641699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.